InvestorsHub Logo
Post# of 156175
Next 10
Followers 9
Posts 920
Boards Moderated 0
Alias Born 04/21/2014

Re: None

Tuesday, 11/21/2017 5:53:55 PM

Tuesday, November 21, 2017 5:53:55 PM

Post# of 156175
OMHE’s_Licensed_Medical_Marijuana_Cultivation_Coming_SOON

OMHE's good days are ahead. Most of the Medical Marijuana R&D companies are in their initial stages of Cannabinoid_based Therapy & Medicine development. OMHE's researchers are best among all and OMHE's work is in advanced (final) stages.

Link To The News

I am delighted to report that we reached the end of a long process that began over ten months ago, culminating in the several high-profile developments we will soon be announcing. There have been extensive negotiations that we have not talked about publicly, but as we are now in the final stages of these negotiations, we can now speak more openly about two important developments that will bring the Company to a completely new level of success.

The first, which we can share now, is development in the sphere of a cannabinoid-based drug-development. In collaboration with Dr. Karyemaitre Aliffe, MD, Omni Health is finalizing a regulatory path to commercialization of a breakthrough, proprietary compound agent with the potential to treat chronic pain.



On 2/9/2017 OMHE CEO released 1st letter (Click Here to Read) to shareholders and most of the promises have been fulfilled as we can see Here and here in this 11/14/2017 CEO's 2nd Letter. One more the most important promise was licensed medical marijuana cultivation plan and I am expecting that will be implemented in next few months.

From 2/9/2017 Letter

We will continue to innovate and continue to build on what we've accomplished. To do so, our vision is to capitalize on decades of knowledge and experience to create a global health and wellness company. To that end, we plan to rapidly expand our operations to include new divisions in the areas of (1) specialty pharmaceuticals, (2) anti-aging brands, and (3) therapeutic cannabis products and (4) licensed medical marijuana cultivation. Currently, we are in the final states of several strategic acquisitions to accelerate our bold expansion. Our pipeline of new products and breakthrough innovation has never been more robust.



Status, as of Nov 2017

(1) Specialty Pharmaceuticals –----------------- Completed - Click here to see proof
(2) Anti-Aging Brands –---------------------------- Completed - Click here to see proof
(3) Therapeutic Cannabis Products –---------- Completed - Click here to see proof
(4) Licensed Medical Marijuana Cultivation – INPROGRESS – WILL BE ANNOUNCED SOON

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.